|
US3267139A
(en)
*
|
1963-09-24 |
1966-08-16 |
Smith Kline French Lab |
Nu'-trimethylacetyl-nu-phenylalkyl-sulfamides and-phenylcyclopropylsulfamides
|
|
US3320314A
(en)
*
|
1964-01-22 |
1967-05-16 |
Sandoz Ag |
Chlorobenzyl sulfamides
|
|
US3455927A
(en)
*
|
1966-11-17 |
1969-07-15 |
Smithkline Corp |
Phenylpiperazinylalkylsulfamides
|
|
US3531523A
(en)
*
|
1967-07-18 |
1970-09-29 |
Upjohn Co |
N-(phenoxyphenyl)sulfamides
|
|
US3860723A
(en)
*
|
1972-02-09 |
1975-01-14 |
Smithkline Corp |
Methods and compositions for increasing feed intake of animals
|
|
CH618308B
(de)
*
|
1976-06-25 |
1900-01-01 |
Ciba Geigy Ag |
Verfahren zum flammfestmachen von textilmaterialien aus polyester mit substituierten sulfurylamiden.
|
|
GB9702194D0
(en)
|
1997-02-04 |
1997-03-26 |
Lilly Co Eli |
Sulphonide derivatives
|
|
AU741742B2
(en)
|
1998-02-24 |
2001-12-06 |
Eli Lilly And Company |
Sulphonamide derivatives
|
|
AR049646A1
(es)
*
|
2004-06-16 |
2006-08-23 |
Janssen Pharmaceutica Nv |
Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
|
|
MY147767A
(en)
*
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
ATE400565T1
(de)
*
|
2004-08-24 |
2008-07-15 |
Janssen Pharmaceutica Nv |
Als antikonvulsive mittel geeignete neue benzokondensierte heteroarylsulfamidderivate
|
|
EP1881959A1
(en)
*
|
2005-05-20 |
2008-01-30 |
Janssen Pharmaceutica N.V. |
Process for preparation of sulfamide derivatives
|
|
US8937096B2
(en)
*
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
US8492431B2
(en)
*
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
|
US20070155823A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
|
|
US8716231B2
(en)
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
US8691867B2
(en)
*
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
US8497298B2
(en)
*
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US20070155827A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
|
|
US20070191474A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
|
|
TW200812573A
(en)
*
|
2006-05-19 |
2008-03-16 |
Janssen Pharmaceutica Nv |
Co-therapy for the treatment of epilepsy and related disorders
|
|
US20090247617A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Abdel-Magid Ahmed F |
Process for the preparation of benzo-fused heteroaryl sulfamates
|
|
CA2729056A1
(en)
|
2008-06-23 |
2010-01-21 |
Janssen Pharmaceutica Nv |
Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
|
|
US8815939B2
(en)
*
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|